Evidence map›Paper›PMID 40404944›Full record

ReviewClinical rheumatology2025

Takayasu arteritis complicated by SAPHO syndrome: A case-based review.

Shu Sugimoto, Dai Kishida, Tatsuya Kobayashi, Naoki Tanomogi, Jun-Ichi Kurashina, Takanori Ichikawa, Yasuhiro Shimojima, Yoshiki Sekijima

Abstract readCase ReportsReview
In one paragraph

Review in Clinical rheumatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shu SugimotoDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Dai KishidaDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan. dkishida@shinshu-u.ac.jp.ORCID http://orcid.org/0000-0001-8309-7984
Tatsuya KobayashiDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Naoki TanomogiDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Jun-Ichi KurashinaDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Takanori IchikawaDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Yasuhiro ShimojimaDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.
Yoshiki SekijimaDepartment of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto, 390-8621, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Takayasu arteritis (TAK) is often associated with other inflammatory diseases. Here, we describe two Japanese patients with TAK complicated by synovitis, acne, pustulosis, hyperostosis, and osteitis (SAPHO) syndrome. Both patients presented with anterior chest pain as their chief complaint and were diagnosed with TAK following SAPHO syndrome. Treatment with glucocorticoids and biological agents led to a rapid improvement in symptoms. A review of the literature identified 11 additional cases of TAK complicated by SAPHO syndrome. SAPHO syndrome frequently precedes TAK, with the diagnostic interval between the two diseases ranging from 1 month to 12 years. No clear association was found between the sites of osteoarticular and vascular involvement. These findings suggest that SAPHO syndrome may be a comorbid condition in patients with TAK. As TAK may develop several years after the diagnosis of SAPHO syndrome, clinicians should consider the possibility of TAK in patients presenting with severe inflammation that cannot be fully explained by SAPHO syndrome alone.

Indexed as

Acquired Hyperostosis SyndromeTakayasu ArteritisAdultFemaleGlucocorticoidsHumansMaleMiddle AgedGlucocorticoidsBiological agentsChest painSAPHO syndromeTakayasu arteritis

Identifiers

PMID40404944
PMCPMC12234600

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.